You are viewing an expired study

This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please browse nearby listings below.

Click here to view additional nearby studies or search for clinical trials.

Rochester, Minnesota 55905

  • Complex Regional Pain Syndrome, Type 1

Purpose:

The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 (CRPS).


Criteria:

Inclusion Criteria: 1. Age > or = to 18 years 2. Signed consent form 3. A diagnosis of CRPS type I for at least one-year duration with unilateral involvement of a distal limb 4. CRPS pain intensity score at least 4 on an 11-point PI-NRS 5. Measurable sural, median sensory, median motor and peroneal motor nerve conductions 6. Women of childbearing potential must have a negative serum or urine pregnancy test within 7 days of starting the study drug. They must agree to use adequate contraceptive methods not including steroid-based contraceptives. They must also agree to have pregnancy tests every 4 weeks while on the study drug.


NCT ID:

NCT00166452


Primary Contact:

Principal Investigator
Keith A Bengtson, M.D.
Mayo Clinic


Backup Contact:

N/A


Location Contact:

Rochester, Minnesota 55905
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 26, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.